| Physiology of the Calcium-Parathyroid Hormone-Vitamin D Axis |
20 |
| Metabolic Syndrome in Polycystic Ovary Syndrome |
11 |
| Vitamin D and Diabetes Mellitus |
10 |
| Metabolic Syndrome in Cushing's Syndrome Patients |
9 |
| Parathyroid Carcinoma |
9 |
| Metabolic Syndrome in Male Hypogonadism |
8 |
| Secondary and Tertiary Hyperparathyroidism |
8 |
| In utero Androgen Excess: A Developmental Commonality Preceding Polycystic Ovary Syndrome? |
6 |
| Vitamin D Assays |
6 |
| Metabolic Syndrome in Hypopituitarism |
5 |
| The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism |
5 |
| Obesity and Androgens in Women |
5 |
| Extra-Skeletal Effects of Vitamin D |
4 |
| Asymptomatic Primary Hyperparathyroidism |
4 |
| Familial and Hereditary Forms of Primary Hyperparathyroidism |
4 |
| Metabolic Syndrome in Parathyroid Diseases |
4 |
| Metabolic Syndrome in Thyroid Disease |
4 |
| Metabolic Syndrome in Hyperprolactinemia |
3 |
| Normocalcemic Hyperparathyroidism |
3 |
| Vitamin D and Secondary Hyperparathyroid States |
3 |
| New Concepts in Vitamin D Requirements for Children and Adolescents: A Controversy Revisited |
3 |
| Understanding the Role of Androgen Action in Female Adipose Tissue |
3 |
| Androgens, Body Composition, and Their Metabolism Based on Sex |
3 |
| Hypercalcemic States Associated with Abnormalities of Vitamin D Metabolism |
2 |
| Physiology and Pathophysiology of Water Homeostasis |
2 |
| Etiology and Epidemiology of Hyponatremia |
2 |
| Inactivating PTH/PTHrP Signaling Disorders |
2 |
| A New Era for Chronic Management of Hypoparathyroidism: Parathyroid Hormone Peptides |
2 |
| Clinical Presentation of Hypoparathyroidism |
2 |
| Hyponatremia-Inducing Drugs |
2 |
| Metabolic Complications in Adrenal Insufficiency |
2 |
| Metabolic Complications of Acromegaly |
1 |
| Exercise-Associated Hyponatremia |
1 |
| The Diagnostic Approach to the Patient with Hyponatremia: Are the Correct Investigations Being Done? |
1 |
| Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome |
1 |
| Vitamin D and Primary Hyperparathyroidism |
1 |
| Vitamin D and Glucocorticoid-Induced Osteoporosis |
1 |
| Primary Hyperparathyroidism |
1 |
| Euvolemic Hyponatremia Secondary to the Syndrome of Inappropriate Antidiuresis |
1 |
| Morbidity and Mortality of Hyponatremia |
1 |
| Hypoparathyroidism |
1 |
| Conventional Treatment of Hypoparathyroidism |
1 |
| Androgens in Congenital Adrenal Hyperplasia |
1 |
| Androgen-Secreting Ovarian Tumors |
0 |
| The Role of Androgen Excess on Insulin Sensitivity in Women |
0 |
| Hyperandrogenism and Adrenocortical Tumors |
0 |
| Androgens in Cushing's Syndrome |
0 |
| Classification of Hypoparathyroid Disorders |
0 |
| Hypervolemic Hyponatremia (Liver) |
0 |
| Hypovolemic Hyponatremia |
0 |
